Incidence of leukopenia after intraperitoneal vs combined intravenous/intraperitoneal chemotherapy in pseudomyxoma peritonei

doi:10.4292/wjgpt.v7.i3.434

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7456)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

526

WORD

395

HTML

2635

Figures (1-1)

218

Tables (1-2)

239

Sum=4013

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1094

Download

2348

Sum=3442

Aug 6, 2016 (publication date) through Dec 28, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pharmacology and Therapeutics

ISSN

2150-5349

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Pharmacol Ther. Aug 6, 2016; 7(3): 434-439
Published online Aug 6, 2016. doi: 10.4292/wjgpt.v7.i3.434

Table 2 Clinicopathological characteristics of patients with and without leukopenia

	Leukopenia	No leukopenia
No.	10	32
Gender
Male	3	16
Female	7	16
Age (yr)	60 ± 16	48.5 ± 11
MMC	10	22
OX/5-FU	0	10
Splenectomy	2	12
Hospital stay (d)	25 ± 12	20 ± 10
Length of operation (h)	08:54 ± 01:44	09:48 ± 02:28
HAP	2	0
SSI	1	1
PE	2	2
IAA	0	1
UTI	1	0

HAP: Hospital-acquired pneumonia; SSI: Surgical site infections; IAA: Intraabdominal abscess formation; PE: Pleural effusion; UTI: Urinary tract infection; MMC: Mitomycin C; OX/5-FU: Oxaliplatin/5-fluorouracil.

Citation: Horvath P, Beckert S, Struller F, Königsrainer A, Königsrainer I. Incidence of leukopenia after intraperitoneal vs combined intravenous/intraperitoneal chemotherapy in pseudomyxoma peritonei. World J Gastrointest Pharmacol Ther 2016; 7(3): 434-439
URL: https://www.wjgnet.com/2150-5349/full/v7/i3/434.htm
DOI: https://dx.doi.org/10.4292/wjgpt.v7.i3.434